ERBB2 and breast cancer: In clinical treatment, endocrine therapy (ET) is seen as the standard treatment for Luminal BC, chemotherapy is the preferred treatment for TNBC, targeted therapy is commonly used for HER2 positive BC treatment, and immunotherapy has been demonstrated to have the best therapeutic efficacy in TNBC, so it is most widely used in the treatment of TNBC.